Collectively, these data suggest an unrecognized mechanism of miR-107/GRN regulation in response to ionizing radiation, which provide a potential therapeutic strategy for improving radiosensitivity of prostate cancer. The gene discussed is GRN; the disease is prostate carcinoma.